Bill Title: To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2022-05-03 - Referred to the House Committee on Energy and Commerce. [HB7640 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2022-05-04	PDF	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress HB7640

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress HB7640 currently on file.

Social Comments on US HB7640